Abstract
Idiopathic dilated cardiomyopathy (IDC) is a heart muscle disease of unknown origin characterized by enlargement and systolic dysfunction of the left ventricle, with or without overt cardiac failure. Although IDC remains a serious condition with significant morbidity and mortality [1–6], an improving prognosis has been shown in recent years [7–10] and the favourable effect of new treatments on the survival of patients is impressive [9, 10]. Moreover, a progressive increase in the number of patients with IDC and a shorter duration of symptoms before diagnosis were found [7–10], suggesting that a more extensive and earlier detection of the disease may have contributed to modifying the natural history of IDC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fuster V, Gersh BJ, Giuliani ER et al (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525–531
Franciosa JA, Wilen M, Ziesche S et al (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51: 831–836
Unverferth DV, Magorien RD, Moeschberger ML et al (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152
Costanzo-Nordin MR, O’Connel JB, Engelmeier RS et al (1985) Dilated cardiomyopathy: funtional status, hemodynamics, arrhythmias, and prognosis. Cathet Cardiovasc D iagn 11: 445–4530
Diaz RA, Obasohan A, Oakley CM (1987) Prediction of outcome in dilated cardiomyopathy. Br Heart J 58: 393–399
Stevenson LW, Fowler MB, Schroeder JS et al (1987) Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Med 83: 871–876
Codd MB, Sugrue DD, Gersh BJ et al (1989) Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation 80: 564–572
Sugrue DD, Rodeheffer RJ, Codd MB et al (1992) The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 117: 117–123
Redfield MM, Gersh BJ, Bailey KR et al (1993) Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol 22: 1921–1926
Di Lenarda A, Secoli G, Perkan A et al (1994) Changing mortality in dilated cardiomyopathy. Br Heart J 72 [suppl]: S46–551
Gavazzi A, Lanzarini L, Cornalba C et al (1984) Dilated (congestive) cardiomyopathy. G Ital Cardiol 12: 492–498
Komajda M, Jais JP, Reeves F et al (1990) Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 11: 824–831
Razzolini R, Boffa GM, Stritoni P et al (1989) Storia naturale delle miocardiopatie dilatative. G Rai Cardiol 19: 114–120
Fowles RE (1990) Natural history and prognosis of overt dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York, pp 337–346
Captopril Multicenter Research Group (1983) A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 24: 755–763
Furberg CD, Yusuf S (1985) Effect of vasodilatators on survival in chronic congestive heart failure. Am J Cardiol 55: 1110–1113
Cohn JN, Archibald DG, Ziesche S (1986) Effect of vasodilatator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 314: 1547–1552
The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435
The Captopril-Digoxin Multicenter Research Group (1988) Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 259: 539–544
Cohn JN, Johnson G (1990) Heart failure with normal ejection fraction: the V-HeFT study. Circulation 811Suppl III]: 48–53
The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302
Cohn JN, Johnson G, Ziesche S et al (1991) A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303–310
The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691
Pfeffer MA, Braunwald E, Moyè LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677
Carson P, Johnson G, Fletcher R et al (1996) Mild systolic dysfunction in heart failure (left venticular ejection fraction 35%): baseline characteristics, prognosis and response to therapy in the vasodilatator in heart failure trials (V-HeFT). J Am Coll Cardiol 27 (3): 642–649
Waagstein F, Bristow MR, Swedberg K et al (1993) Beneficial effects of metoprolol in dilated cardiomyopathy. Lancet 342: 1441–1446
CIBIS Investigators and Committees (1994) A randomized trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90: 17651773
Packer M, Bristow MR, Cohn JN et al (1996) For the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349–1355
CIBIS II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353: 9–13
Merit HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metropol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353: 2001–2007
Steimle AE, Stevenson LW, Fonarow GC et al (1994) Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 23: 553559
Daly K, Richardson PJ, Olsen EGJ et al (1984) Acute myoacarditis-role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J 51: 30–35
Dec GW, Igor FP, Fallon JT et al (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies-clinical features, histologic correlates and clinical outcome. N Engl J Med 312: 885–890
Mortensen SA, Baandrup U, Buch J et al (1985) Immunosuppressive therapy of biopsy proven myocarditis: experiences with corticosteroids and cyclosporine. Int J Immunother 1: 35–45
Quigley PJ, Richardson PJ, Meany BT et al (1987) Long-term follow-up of acute myocarditis: correlation of ventricular function and outcome. Eur Heart J 8 [Suppl J]: 39–42
Salvi A, Hrovatin E, Dreas L et al (1987) Changes in histology and left ventricular ejection fraction during immunosuppressive treatment in active myocarditis. Eur Heart J 8 [Suppl J]: 267–269
Anguita M, Arizon JM, Bueno G et al (1992) Spontaneous clinical and hemodynamic improvement in patients on waiting list for heart transplantation. Chest 102: 96–99
Rokman HA, Adamson RM, Dembitsky WP et al. (1991) Acute fulminant myocarditis: long term follow-up after circulatory support with left ventricular assist device. Am Heart J 121: 922–926
Stevenson LW (1996) Timing of adult cardiac transplantation. Cardiologia 41: 117–128
Redfield MM, Gersh BJ, Bailey KR et al (1994) Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy. Am J Cardiol 74: 737–739
Di Lenarda A, Gregori D, Sinagra G et al (1996) Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? J Cardiac Failure 2 (2): 87–102
World Health Organization/International Society and Federation of Cardiology (1980) Task force on the definition and classification of cardiomyopathies. Br Heart J 44: 672–673
Report of the 1995 World Health Organization/International Society and Federation of Cardiology (1996) Task force on the definition and classification of cardiomyopathies. Circulation 93: 841–843
Di Lenarda A, Gregori D, Lardieri G et al (1995) Progressiva riduzione della risposta al trattamento in pazienti con cardiomiopatia dilatativa e lunga storia di scompenso cardiaco. G Ital Cardiol; 25 [suppl 1J: 331
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Italia
About this paper
Cite this paper
Sinagra, G., Di Lenarda, A., Sabbadini, G. (2001). Dilated Cardiomyopathy and Steps in the Treatment. In: Atlee, J.L., Vincent, JL. (eds) Critical Care Cardiology in the Perioperative Period. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-2955-2_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-2955-2_11
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0133-6
Online ISBN: 978-88-470-2955-2
eBook Packages: Springer Book Archive